Syon Capital’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$266K Sell
1,264
-170
-12% -$34.1K 0.01% 976
2026
Q2
$273K Buy
1,434
+3
+0.2% +$516 0.01% 833
2026
Q1
$242K Buy
1,431
+228
+19% +$39K 0.01% 817
2025
Q4
$203K Buy
+1,203
New +$195K 0.01% 867
2025
Q2
– Sell
-4,119
Closed -$527K – 752
2025
Q1
$527K Sell
4,119
-3,623
-47% -$491K 0.04% 299
2024
Q4
$1.02M Buy
+7,742
New +$1.09M 0.09% 157

Other funds holding IBB

Syon Capital's IBB Position: Q3 2026 in Review

Syon Capital reduced its iShares Biotechnology ETF (IBB) stake by 12% in Q3 2026, selling an estimated $34.1K and leaving 1,264 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #976.

Syon Capital first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.02M in Q4 2024. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Syon Capital held 1,264 shares of iShares Biotechnology ETF worth $266K as of Q3 2026.
  • Syon Capital sold 170 iShares Biotechnology ETF shares in Q3 2026, an estimated $34.1K.
  • iShares Biotechnology ETF made up 0.01% of Syon Capital's portfolio in Q3 2026, its #976 holding.
  • Syon Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • Syon Capital's iShares Biotechnology ETF position peaked at $1.02M in Q4 2024.
  • 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.